Global Cord Blood Corporation (CORBF)

USD 1.06

(11.58%)

Operating Income Summary of Global Cord Blood Corporation

  • Global Cord Blood Corporation's latest annual operating income in 2021 was 94.87 Million CNY , up 18.06% from previous year.
  • Global Cord Blood Corporation's latest quarterly operating income in 2021 FY was 94.87 Million CNY , up 18.06% from previous quarter.
  • Global Cord Blood Corporation reported an annual operating income of 80.36 Million CNY in 2020, up 0.15% from previous year.
  • Global Cord Blood Corporation reported an annual operating income of 80.24 Million CNY in 2019, up 41.11% from previous year.
  • Global Cord Blood Corporation reported a quarterly operating income of 94.87 Million CNY for 2021 FY, up 18.06% from previous quarter.
  • Global Cord Blood Corporation reported a quarterly operating income of 23.41 Million USD for 2021 Q3, down -5.59% from previous quarter.

Annual Operating Income Chart of Global Cord Blood Corporation (2021 - 2016)

Historical Annual Operating Income of Global Cord Blood Corporation (2021 - 2016)

Year Operating Income Operating Income Growth
2021 94.87 Million CNY 18.06%
2020 80.36 Million CNY 0.15%
2019 80.24 Million CNY 41.11%
2018 56.86 Million USD 34.67%
2017 42.22 Million USD 19.11%
2016 35.45 Million USD 0.0%

Peer Operating Income Comparison of Global Cord Blood Corporation

Name Operating Income Operating Income Difference
American Bio Medica Corporation -1.24 Million USD 7739.162%
Arrayit Corporation -3.62 Million USD 2719.128%
Atlantic International Corp. -5.73 Million USD 1755.094%
Biocept, Inc. -31.98 Million USD 396.653%
Bioqual, Inc. -19.63 Thousand USD 483236.725%
CardioGenics Holdings Inc -772.14 Thousand USD 12387.687%
DermTech, Inc. -103.73 Million USD 191.459%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 2.48 Billion USD 96.185%
HTG Molecular Diagnostics, Inc. -20.82 Million USD 555.498%
iMD Companies, Inc. -175.44 Thousand USD 54178.4%
IDenta Corp. -1499.00 USD 6329545.63%
Interpace Biosciences, Inc. 2.8 Million USD -3283.68%
Integrative Health Technologies, Inc. 38.69 Thousand USD -245127.165%
InVitro International -25.33 Thousand USD 374536.205%
Lumos Diagnostics Holdings Limited -7.12 Million USD 1432.187%
Many Bright Ideas Technologies Inc. -58.11 Thousand USD 163368.155%
Medical Imaging Corp. -819.48 Thousand USD 11677.877%
NovelStem International Corp. -3.52 Million USD 2790.976%
Optigenex Inc. 1.39 Million USD -6721.686%
PharmChem, Inc. 973.14 Thousand USD -9649.646%
Proteome Sciences plc -1.62 Million USD 5953.078%
Response Genetics, Inc -21.37 Million USD 543.834%
Rennova Health, Inc. -1.4 Million USD 6831.188%
RushNet, Inc. -684.7 Thousand USD 13956.827%
ScreenPro Security Inc. -2.59 Million USD 3759.827%
Stella Diagnostics Inc. -11.42 Million USD 930.304%
StageZero Life Sciences Ltd. -7.74 Million USD 1324.749%
Todos Medical Ltd. -9.74 Million USD 1073.311%